Roche to Invest $50 Bn in US Mfg & R&D Over Five Years 
By

By
Roche has announced that it will invest $50 billion in existing and new research and development (R&D) and manufacturing  facilities in its pharmaceuticals and diagnostics operations in the US in…

Fujifilm, Regeneron in 10-Year, $3-Bn US Mfg Pact 
By

By
Fujifilm Diosynth Biotechnologies, a CDMO of biologics and advanced therapies, has entered a 10-year manufacturing supply agreement, valued at over $3 billion, with Regeneron Pharmaceuticals, a Tarrytown, New York-based bio/pharmaceutical…

PCI Pharma Services To Acquire Fill-Finish CDMO Ajinomoto Althea 
By

By
PCI Pharma Services, a Philadelphia, Pennsylvania-based CDMO, has agreed to acquire the entire equity stake in Ajinomoto Althea, a San Diego, California-based sterile fill–finish CDMO and 100% subsidiary of the…

Supplier News: Phlow, Evotec & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Phlow, Evotec and Eversana.   Chemicals/Chemical API Manufacturing * Phlow Expands Analytical Capabilities, Advances AI in Mfg General * Evotec Provides Update to Strategic Plan * Eversana…

Mfg News: Bayer & Ferring 
By

By
A roundup of manufacturing news from Bayer and Ferring Pharmaceuticals. Highlights below.  * Bayer Opens $44-M Packaging, Logistics Expansion for Consumer Healthcare Products * Ferring Pharmaceuticals Opens Gene-Therapy Mfg Site  Bayer Opens…

Global Briefs: Jazz Pharmaceuticals, Genentech, Galapagos & More 
By

By
A roundup of news from Jazz Pharmaceuticals/Chimerix, Genentech/Repertoire, Galapagos, and Asahi Kasei. Highlights below.   M&A News * Jazz Pharmaceuticals Completes $935-M Acquisition of Chimerix Partnering News * Genentech, Repertoire in $765-M Autoimmune Disease…

Congress Calls for $15 Bn in US Gov’t Funding To Spur Biotechnology Competitiveness
By

By
The National Security Commission on Emerging Biotechnology (NSCEB), a US legislative commission, issued a report last week (April 8, 2025) that outlined an action plan for improving US competitiveness in…

Kyowa Kirin Completes Construction of New Biomanufacturing Facility in Japan 
By

By
Kyowa Kirin, a Tokyo-based bio/pharmaceutical company, has completed the construction of a new JPY 16.8-billion ($118-million) biologics drug-substance manufacturing facility at its site in Takasaki, Japan. The GMP facility will include…

Supplier News Roundup: Lonza, Thermo Fisher, Schott, Meribel & More
By

By
The latest from CDMOs, CMOs, and suppliers featuring Lonza, Thermo Fisher, Schott, and Meribel Pharma Solutions. Chemicals/Chemical API Manufacturing* Lonza Joins Center for Continuous Manufacturing and Advanced CrystallizationBiologics Manufacturing* Thermo…

Partnering News: GSK, Sanofi, Lilly, Merck & Co. & BI 
By

By
A roundup of bio/pharmaceutical partnering news from GSK/ABL Bio, Sanofi/Earendil Labs, Lilly/ Sangamo Therapeutics, Merck & Co./Cyprumed, and Boehringer Ingelheim/Cue Biopharma. Highlights below.   * GSK, ABL Bio in $2.85-Bn Bispecific…